Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 03, 2023

BUY
$4.65 - $7.37 $130,939 - $207,531
28,159 New
28,159 $136,000
Q3 2022

Nov 14, 2022

BUY
$4.65 - $7.37 $10,699 - $16,958
2,301 Added 8.9%
28,159 $136,000
Q2 2022

Aug 15, 2022

BUY
$4.21 - $11.15 $21,024 - $55,683
4,994 Added 23.94%
25,858 $119,000
Q1 2022

May 16, 2022

BUY
$8.48 - $18.1 $16,188 - $34,552
1,909 Added 10.07%
20,864 $224,000
Q4 2021

Feb 14, 2022

BUY
$15.37 - $22.5 $291,338 - $426,487
18,955 New
18,955 $324,000

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.